fbpx
December 19, 2022

Long COVID Risk Makes It Worth Avoiding Second Infections Long COVID Risk Makes It Worth Avoiding Second Infections

Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. Alexander Truong, MD, has been seeing long COVID patients for more […]
December 19, 2022

New Pediatrics Growth Charts Better Reflect Severe Obesity New Pediatrics Growth Charts Better Reflect Severe Obesity

The U.S. Centers for Disease Control and Prevention has issued extended growth charts to help doctors and researchers better understand patterns of development for the most […]
December 19, 2022

Formula-Fed Extreme Preemies Need More Iron: Study Formula-Fed Extreme Preemies Need More Iron: Study

NEW ORLEANS – Researchers are calling for a revision of neonatal guidelines in light of new study results from Canada showing that most extremely premature infants fed with […]
December 19, 2022

Upadacitinib Curbs UC Symptoms From Day 1: Study Upadacitinib Curbs UC Symptoms From Day 1: Study

Patients with ulcerative colitis who were treated with upadacitinib showed significant improvement in symptoms compared to placebo within days of starting treatment, according to results of […]
December 19, 2022

Building a Social Media Presence: Tips From ‘Dr Pimple Popper’ Building a Social Media Presence: Tips From ‘Dr Pimple Popper’

SAN DIEGO – In the fall of 2014, Sandra Lee, MD, posted a blackhead extraction video on her Instagram account, a decision that changed her professional life forever. […]
December 19, 2022

DELIVER Subanalysis ‘Seals Deal’ for Dapagliflozin in HF DELIVER Subanalysis ‘Seals Deal’ for Dapagliflozin in HF

A prespecified analysis of a large global trial of patients with symptomatic heart failure with mildly reduced and preserved ejection fraction “seals the deal” on the […]
December 19, 2022

CLL Phase 3 Study: Zanubrutinib Bests Ibrutinib CLL Phase 3 Study: Zanubrutinib Bests Ibrutinib

Zanubrutinib (Brukinsa) demonstrated superior efficacy and safety over ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia (CLL), according to results of the randomized, phase […]
December 19, 2022

Combo Therapy for Advanced NSCLC Provides PFS Benefit Combo Therapy for Advanced NSCLC Provides PFS Benefit

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway In patients with epidermal […]
December 19, 2022

HIV Outbreak Persists as Officials Push Back HIV Outbreak Persists as Officials Push Back

CHARLESTON, W.Va. — Brooke Parker has spent the past two years combing riverside homeless encampments, abandoned houses, and less traveled roads to help contain a lingering […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0